Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males

Neuropsychopharmacology

Volumn 41, Issue 10, 2016, Pages 2596-2605

  Wiers, Corinde E ^a   Shokri Kojori, Ehsan ^a   Wong, Christopher T ^a   Abi Dargham, Anissa ^b   Demiral, Şükrü B ^a   Tomasi, Dardo ^a   Wang, Gene Jack ^a   Volkow, Nora D ^a,c  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; DOPAMINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; METHYLPHENIDATE; PLACEBO; CENTRAL STIMULANT AGENT;

ADULT; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CANNABIS ADDICTION; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; EMOTIONALITY; FEMALE; FRONTAL CORTEX; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; MALE; MESENCEPHALON; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; THALAMUS; BRAIN; DIAGNOSTIC IMAGING; DRUG EFFECTS; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; PATHOLOGY; PERSONALITY TEST; PSYCHOLOGICAL RATING SCALE; SEXUAL DEVELOPMENT; STATISTICS; YOUNG ADULT;

ADULT; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MARIJUANA ABUSE; METHYLPHENIDATE; MIDDLE AGED; PERSONALITY INVENTORY; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; SEX CHARACTERISTICS; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84973098743     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2016.67     Document Type: Article

References (62)

1. Berridge CW, Arnsten AF (2013). Psychostimulants and motivated behavior: arousal and cognition. Neurosci Biobehav Rev 37(9 Pt A): 1976-1984.
2. Bloomfield MA, Morgan CJ, Egerton A, Kapur S, Curran HV, Howes OD (2014a). Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry 75: 470-478.
3. Bloomfield MA, Morgan CJ, Kapur S, Curran HV, Howes OD (2014b). The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study. Psychopharmacology 231: 2251-2259.
4. Carvalho AF, Van Bockstaele EJ (2012). Cannabinoid modulation of noradrenergic circuits: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 38: 59-67.
5. Cathel AM, Reyes BA, Wang Q, Palma J, Mackie K, Van Bockstaele EJ et al (2014). Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex. Eur J Neurosci 40: 3202-3214.
6. Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK (1998). Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 50: 27-37.
7. De Santi S, de Leon MJ, Convit A, Tarshish C, Rusinek H, Tsui WH et al (1995). Age-related changes in brain: II. Positron emission tomography of frontal and temporal lobe glucose metabolism in normal subjects. Psychiatr Q 66: 357-370.
8. Dumont GJ, Kramers C, Sweep FC, Touw DJ, van Hasselt JG, de Kam M et al (2009). Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. Clin Pharmacol Ther 86: 160-166.
9. Fattore L, Altea S, Fratta W (2008). Sex differences in drug addiction: a review of animal and human studies. Womens Health (Lond Engl) 4: 51-65.
10. Fattore L, Fratta W (2010). How important are sex differences in cannabinoid action? Br J Pharmacol 160: 544-548.
11. Fogel JS, Kelly TH, Westgate PM, Lile JA (e-pub ahead of print 15 January 2016). Sex differences in the subjective effects of oral Delta-THC in cannabis users. Pharmacol Biochem Behav.
12. Goldstein RZ, Volkow ND (2011). Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12: 652-669.
13. Goldstein RZ, Woicik PA, Maloney T, Tomasi D, Alia-Klein N, Shan J et al (2010). Oral methylphenidate normalizes cingulate activity in cocaine addiction during a salient cognitive task. Proc Natl Acad Sci USA 107: 16667-16672.
14. Gorzalka BB, Dang SS (2012). Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 153: 1016-1024.
15. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
16. Hasin DS, Keyes KM, Alderson D, Wang S, Aharonovich E, Grant BF (2008). Cannabis withdrawal in the United States: results from NESARC. J Clin Psychiatry 69: 1354-1363.
17. Heitzeg MM, Cope LM, Martz ME, Hardee JE, Zucker RA (2015). Brain activation to negative stimuli mediates a relationship between adolescent marijuana use and later emotional functioning. Dev Cogn Neurosci 16: 71-83.
18. Higuera-Matas A, Soto-Montenegro ML, Montoya GL, Garcia-Vazquez V, Pascau J, Miguens M et al (2011). Chronic cannabinoid administration to periadolescent rats modulates the metabolic response to acute cocaine in the adult brain. Mol Imaging Biol 13: 411-415.
19. Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C et al (2012). Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 17: 642-649.
20. Jacobus J, Goldenberg D, Wierenga CE, Tolentino NJ, Liu TT, Tapert SF (2012). Altered cerebral blood flow and neurocognitive correlates in adolescent cannabis users. Psychopharmacology 222: 675-684.
21. Khan SS, Secades-Villa R, Okuda M, Wang S, Perez-Fuentes G, Kerridge BT et al (2013). Gender differences in cannabis use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions. Drug Alcohol Depend 130: 101-108.
22. Leroy C, Karila L, Martinot JL, Lukasiewicz M, Duchesnay E, Comtat C et al (2012). Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict Biol 17: 981-990.
23. Lev-Ran S, Imtiaz S, Taylor BJ, Shield KD, Rehm J, Le Foll B (2012). Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 123: 190-200.
24. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19: 1233-1239.
25. Mizrahi R, Suridjan I, Kenk M, George TP, Wilson A, Houle S et al (2013). Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO. Neuropsychopharmacology 38: 673-682.
26. Moeller SJ, Honorio J, Tomasi D, Parvaz MA, Woicik PA, Volkow ND et al (2014). Methylphenidate enhances executive function and optimizes prefrontal function in both health and cocaine addiction. Cerebral Cortex 24: 643-653.
27. Neumeister A, Normandin MD, Pietrzak RH, Piomelli D, Zheng MQ, Gujarro-Anton A et al (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Mol Psychiatry 18: 1034-1040.
28. Normandin MD, Zheng MQ, Lin KS, Mason NS, Lin SF, Ropchan J et al (2015). Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences. J Cereb Blood Flow Metab 35: 1313-1322.
29. Olson L, Fuxe K (1971). On the projections from the locus coeruleus noradrealine neurons: the cerebellar innervation. Brain Res 28: 165-171.
30. Patrick KS, Markowitz JS (1997). Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder. Hum Psychopharm Clin 12: 527-546.
31. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE (1979). Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6: 371-388.
32. Preston P (2006). Marijuana use as a coping response to psychological strain: racial, ethnic, and gender differences among young adults. Deviant Behav 27: 397-421.
33. Puighermanal E, Busquets-Garcia A, Maldonado R, Ozaita A (2012). Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. Philos Trans R Soc Lond B Biol Sci 367: 3254-3263.
34. Reyes BA, Rosario JC, Piana PM, Van Bockstaele EJ (2009). Cannabinoid modulation of cortical adrenergic receptors and transporters. J Neurosci Res 87: 3671-3678.
35. Riebe CJ, Hill MN, Lee TT, Hillard CJ, Gorzalka BB (2010). Estrogenic regulation of limbic cannabinoid receptor binding. Psychoneuroendocrinology 35: 1265-1269.
36. Sara SJ (2009). The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10: 211-223.
37. Silva L, Black R, Michaelides M, Hurd YL, Dow-Edwards D (e-pub ahead of print 16 February 2016). Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. Neurotoxicol Teratol.
38. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD et al (1977). The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28: 897-916.
39. Tellegen A, Waller NG (2008). Exploring personality through test construction: Development of the Multidimensional Personality Questionnaire. In: Boyle GJ, Matthews G, Saklofske DH (eds). The SAGE Handbook of Personality Theory and Assessment 2. Sage Publications, Inc: Thousand Oaks, CA, USA, pp 261-292.
40. Thompson JL, Urban N, Slifstein M, Xu X, Kegeles LS, Girgis RR et al (2013). Striatal dopamine release in schizophrenia comorbid with substance dependence. Mol Psychiatry 18: 909-915.
41. Tilley MR, Gu HH (2008). The effects of methylphenidate on knockin mice with a methylphenidate-resistant dopamine transporter. J Pharmacol Exp Ther 327: 554-560.
42. Urban NB, Slifstein M, Thompson JL, Xu X, Girgis RR, Raheja S et al (2012). Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry 71: 677-683.
43. van de Giessen E, Weinstein JJ, Cassidy CM, Haney M, Dong Z, Ghazzaoui R et al (e-pub ahead of print 22 March 2016). Deficits in striatal dopamine release in cannabis dependence. Mol Psychiatry.
44. Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M et al (2001). Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158: 2015-2021.
45. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS et al (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52: 456-463.
46. Volkow ND, Fowler JS (2000a). Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cerebral Cortex 10: 318-325.
47. Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ et al (1993). Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14: 169-177.
48. Volkow ND, Gillespie H, Mullani N, Tancredi L, Grant C, Valentine A et al (1996). Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication. Psychiatry Res 67: 29-38.
49. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Burr G, Pascani K et al (1992a). Decreased brain metabolism in neurologically intact healthy alcoholics. Am J Psychiatry 149: 1016-1022.
50. Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL et al (1992b). Long-term frontal brain metabolic changes in cocaine abusers. Synapse 11: 184-190.
51. Volkow ND, Logan J, Fowler JS, Wang GJ, Gur RC, Wong C et al (2000b). Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. Am J Psychiatry 157: 75-80.
52. Volkow ND, Morales M (2015a). The brain on drugs: from reward to addiction. Cell 162: 712-725.
53. Volkow ND, Tomasi D, Wang GJ, Fowler JS, Telang F, Goldstein RZ et al (2011). Reduced metabolism in brain "control networks" following cocaine-cues exposure in female cocaine abusers. PloS One 6: e16573.
54. Volkow ND, Tomasi D, Wang GJ, Telang F, Fowler JS, Logan J et al (2013). Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism. J Neurosci 33: 4527-4535.
55. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS et al (1998). Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155: 1325-1331.
56. Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ et al (1999). Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry 156: 19-26.
57. Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R et al (1997). Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Am J Psychiatry 154: 50-55.
58. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L et al (2003). Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 23: 11461-11468.
59. Volkow ND, Wang GJ, Shokri Kojori E, Fowler JS, Benveniste H, Tomasi D (2015b). Alcohol decreases baseline brain glucose metabolism more in heavy drinkers than controls but has no effect on stimulation-induced metabolic increases. J Neurosci 35: 3248-3255.
60. Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J et al (2014). Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci USA 111: E3149-E3156.
61. Volkow ND, Wang GJ, Telang F, Fowler JS, Goldstein RZ, Alia-Klein N et al (2009). Inverse association between BMI and prefrontal metabolic activity in healthy adults. Obesity 17: 60-65.
62. Wang GJ, Volkow ND, Roque CT, Cestaro VL, Hitzemann RJ, Cantos EL et al (1993). Functional importance of ventricular enlargement and cortical atrophy in healthy subjects and alcoholics as assessed with PET, MR imaging, and neuropsychologic testing. Radiology 186: 59-65.